Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

The current spotlight on the human metapneumovirus (HMPV) — discovered for the first time in 2001 — a longstanding ...

They provided evidence to guide treatment decisions for COPD patients. Study: Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease ...

DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...

a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched pairs of ...

Metered-dose inhaler ... or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14) compared with the dry-powder competitor fluticasone-umeclidinium-vilanterol (Trelegy Ellipta) over median follow ...

Results The study cohort included 20 388 propensity score matched pairs of new users initiating single inhaler triple therapy. Patients who received budesonide-glycopyrrolate-formoterol had a 9% ...

Triple therapy of an inhaled corticosteroid, long acting β 2-agonist (LABA), and long acting muscarinic antagonist (LAMA) is more effective in reducing the annual rate of exacerbations compared with ...

An outraged Chipotle customer violently attacked an employee behind the counter after she claimed ... Chipotle filed a police report over the alleged assault while the woman intends to sue the ...

A now-viral video shows how the enraged customer walked behind the counter at a Chipotle in northeast Washington DC on Saturday and began making her own burrito bowl. She pushes workers aside as ...

has spilled over from Parliament to the streets with opposition parties trying to make the most of the controversy while the BJP launching a coordinated counter offensive to control the damage.

BOSTON — Compared with 17,800 patients starting new inhaled COPD maintenance therapy in 2016, 32,558 patients started a new inhaled treatment in 2022, according to a presentation at the CHEST ...